NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION UNDER SECTION 12(b) OF THE SECURITIES EXCHANGE ACT OF 1934.
||March 31, 2018
|Estimated average burden|
|hours per response:
|SECURITIES AND EXCHANGE COMMISSION|
|Washington, D.C. 20549|
NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION|
UNDER SECTION 12(b) OF THE SECURITIES EXCHANGE ACT OF 1934.
|Commission File Number
(Exact name of Issuer as specified in its charter, and name of Exchange where security is listed and/or registered)
||142-F North Road, Suite 150
(Address, including zip code, and telephone number, including area code, of Issuer's
principal executive offices)
(Description of class of securities)
Please place an X in the box to designate the rule provision relied upon to strike
the class of securities from listing and registration:
Pursuant to the requirements fo the Securities Exchange Act of 1934,
Nasdaq Stock Market LLC
certifies that it has reasonable grounds to believe that it
meets all of the requirements for filing the Form 25 and has caused this notification to be
signed on its behalf by the undersigned duly authorized person.
Form 25 and attached Notice will be considered compliance with the provisions of
17 CFR 240.19d-1 as applicable. See General Instructions.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
Delisting Determination, The Nasdaq Stock Market, LLC,
September 14, 2022, Allena Pharmaceuticals, Inc.
The Nasdaq Stock Market LLC (the Exchange) has determined
to remove from listing the common stock of Allena
Pharmaceuticals, Inc., effective at the opening
of the trading session on September 26, 2022.
Based on review of information provided by the Company,
Nasdaq Staff determined that the Company no longer qualified
for listing on the Exchange pursuant to Listing Rule 5450(a)(1).
The Company was notified of the Staff determination
on August 23, 2022. The Company appealed the determination
to a Hearing Panel on August 30, 2022. On September 2, 2022,
the Company filed a voluntary petition for relief under the
provisions of Chapter 11 of Title 11 of the United States Code.
On September 6, 2022, the Company infomed of its decision to
withdraw its appeal before a decision was rendered by the Panel.
The Staff determination to delist the Company common stock
became final on September 8, 2022.